Healthcare -
Biotechnology - NASDAQ - US
$ 1.51
0.667 %
$ 41.9 M
Market Cap
-1.99
P/E
INCOME STATEMENT
EFFICIENCY
Earnings Waterfall
Immix Biopharma, Inc.
| Revenue | 0 |
| Cost Of Revenue | 0 |
| Gross Profit | 0 |
| Operating Expenses | 22.7 M |
| Operating Income | -22.7 M |
| Other Expenses | -976 K |
| Net Income | -21.7 M |
Income Statement
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|---|
| REVENUE | ||||||
| Revenue | 0 | 0 | (89.5) | 0 | 0 | 0 |
| GROSS PROFIT | ||||||
| Cost Of Revenue | 0 | 5.47 K | 2.14 K | 2.47 K | 2.32 K | 1.08 K |
| Gross Profit | 0 | 5.47 K | (89.5) | 2.47 K | 2.32 K | 1.08 K |
| OPERATING INCOME | ||||||
| Operating Expenses | 22.7 | 16.1 | 8.2 | 1.4 | 0.5 | 0.8 |
| Selling, General and Administrative Expenses | 11.4 | 7.4 | 4.0 | 1.2 | 0.2 | 0.3 |
| Research and Development Expenses | 11.3 | 8.7 | 4.2 | 0.1 | 0.2 | 0.6 |
| Operating Income | (22.7) | (16.1) | (8.2) | (1.4) | (0.5) | (0.8) |
| PRE-TAX INCOME | ||||||
| Interest Income Expense | 0 | 0 | 497 | 0.2 | 0.1 | 0.1 |
| Total Other Income | 1.0 | 0.6 | 497 | (23.0) | (0.7) | (0.1) |
| Pre-Tax Income | (21.7) | (15.6) | (8.2) | (24.4) | (1.1) | (1.0) |
| NET INCOME | ||||||
| Tax Provision | 41 K | 26.4 K | 10.3 K | 6.01 K | 17.5 K | 20.6 K |
| Net Income | (21.6) | (15.4) | (8.2) | (24.4) | (1.1) | (1.0) |
| EPS | 0.76 | 0.89 | 0.62 | 1.84 | 0.15 | 0.29 |